Aytu BioPharma Ownership | Who Owns Aytu BioPharma?


OverviewForecastRevenueFinancialsChartTranscripts

Aytu BioPharma Ownership Summary


Aytu BioPharma is owned by 57.01% institutional investors, 9.18% insiders, and 33.81% retail investors. Nantahala capital management is the largest institutional shareholder, holding 17.31% of AYTU shares. Philotimo Focused Growth and Income is the top mutual fund, with 2.11% of its assets in Aytu BioPharma shares.

AYTU Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAytu BioPharma57.01%9.18%33.81%
SectorHealthcare Stocks 42.53%10.81%46.67%
IndustrySpecialty & Generic Drug Manufacturers Stocks26.16%11.89%61.94%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Nantahala capital management1.09M17.31%$2.04M
Stonepine capital management891.86K14.20%$1.68M
Awm investment company619.57K9.87%$1.16M
Vanguard group278.58K4.44%$523.74K
Diadema partners lp272.67K4.34%$512.62K
Renaissance95.12K1.51%$178.83K
Geode capital management71.01K1.13%$133.52K
Two sigma investments, lp68.74K1.09%$129.22K
Persistent asset partners62.45K0.99%$117.41K
Two sigma advisers, lp39.80K0.63%$74.82K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Stonepine capital management891.86K1.36%$1.68M
Diadema partners lp272.67K0.13%$512.62K
Awm investment company619.57K0.11%$1.16M
Persistent asset partners62.45K0.08%$117.41K
Nantahala capital management1.09M0.07%$2.04M
Fny investment advisers35.92K0.03%$78.00K
Jaffetilchin investment partners17.44K0.00%$32.78K
Two sigma investments, lp68.74K0.00%$129.22K
Renaissance95.12K0.00%$178.83K
Tower research capital llc (trc)4.32K0.00%$8.13K

Top Buyers

HolderShares% AssetsChange
Diadema partners lp272.67K0.13%272.67K
Vanguard group278.58K-250.69K
Stonepine capital management891.86K1.36%79.18K
Persistent asset partners62.45K0.08%62.45K
Two sigma advisers, lp39.80K0.00%39.80K

Top Sellers

HolderShares% AssetsChange
Kanen wealth management---573.36K
Armistice capital---57.60K
Hrt financial lp---19.99K
Awm investment company619.57K0.11%-300.00
Sbi securities62.00--149.00

New Positions

HolderShares% AssetsChangeValue
Diadema partners lp272.67K0.13%272.67K$512.62K
Persistent asset partners62.45K0.08%62.45K$117.41K
Two sigma advisers, lp39.80K0.00%39.80K$74.82K
Fny investment advisers35.92K0.03%35.92K$78.00K
Dimensional fund advisors lp30.96K-30.96K$58.21K

Sold Out

HolderChange
Northwestern mutual wealth management-1.00
Sjs investment consulting-5.00
Raymond james financial-55.00
Hrt financial lp-19.99K
Armistice capital-57.60K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202529-3,580,1494.81%571.84%1741.67%2-60.00%
Jun 30, 2025307.14%3,416,18182.04%555.95%129.09%6200.00%
Mar 31, 202528-1,876,599-0.22%303.25%11-8.33%2-60.00%
Dec 31, 20242821.74%1,880,741-8.18%303.97%12140.00%5-28.57%
Sep 30, 202423-14.81%2,048,299-0.27%272.02%5-50.00%716.67%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Philotimo Focused Growth and Income189.21K2.11%189.21K
Vanguard Institutional Extnd Mkt Idx Tr62.53K0.70%34.65K
Fidelity Extended Market Index31.77K0.35%-224.00
Spartan Extended Market Index Pool E11.89K0.19%280.00
Spartan Extended Market Index Pool F12.43K0.14%224.00
Fidelity Series Total Market Index8.05K0.09%-
Northern Trust Extended Eq Market Idx6.31K0.07%-
NT Ext Equity Mkt Idx Fd - L6.31K0.07%-
DFA US Targeted Value I3.66K0.06%-5.01K
BlackRock Extended Equity Market K3.56K0.06%-2.00

Recent Insider Transactions


DateNameRoleActivityValue
Jun 09, 2025Disbrow Jarrett Chief Business OfficerBuy$25.00K
Jun 09, 2025Disbrow Joshua R. Chief Executive OfficerBuy$100.00K
Jun 06, 2025Nantahala Capital Management, LLC-Buy$400.00
Feb 28, 2025Disbrow Joshua R. Chief Executive OfficerBuy$19.50K
Jun 16, 2023PYSZCZYMUKA GREG Chief Commerical OfficerBuy$22.43K

Insider Transactions Trends


DateBuySell
2025 Q23-
2025 Q11-
2024 Q4--
2024 Q3--
2024 Q2--

AYTU Ownership FAQ


Who Owns Aytu BioPharma?

Aytu BioPharma shareholders are primarily institutional investors at 57.01%, followed by 9.18% insiders and 33.81% retail investors. The average institutional ownership in Aytu BioPharma's industry, Specialty & Generic Drug Manufacturers Stocks, is 26.16%, which Aytu BioPharma exceeds.

Who owns the most shares of Aytu BioPharma?

Aytu BioPharma’s largest shareholders are Nantahala capital management (1.09M shares, 17.31%), Stonepine capital management (891.86K shares, 14.20%), and Awm investment company (619.57K shares, 9.87%). Together, they hold 41.37% of Aytu BioPharma’s total shares outstanding.

Does Blackrock own Aytu BioPharma?

BlackRock is not among the top 10 institutional shareholders of Aytu BioPharma.

Who is Aytu BioPharma’s biggest shareholder by percentage of total assets invested?

Stonepine capital management is Aytu BioPharma’s biggest shareholder by percentage of total assets invested, with 1.36% of its assets in 891.86K Aytu BioPharma shares, valued at 1.68M$.

Who is the top mutual fund holder of Aytu BioPharma shares?

Philotimo Focused Growth and Income is the top mutual fund holder of Aytu BioPharma shares, with 2.11% of its total shares outstanding invested in 189.21K Aytu BioPharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools